Compound Summary
S15535
Compound Information
S15535
Compound Name: | S15535 |
Compound CID: | 132787 |
Synonyms: | S15535 146998-34-7 S-15535 4-(Benzodioxan-5-yl)-1-(indan-2-yl)piperazine S 15535 More... |
Iupac Name: | 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-(2,3-dihydro-1H-inden-2-yl)piperazine |
InChI: | InChI=1S/C21H24N2O2/c1-2-5-17-15-18(14-16(17)4-1)22-8-10-23(11-9-22)19-6-3-7-20-21(19)25-13-12-24-20/h1-7,18H,8-15H2 |
InChIKey: | QJPPEMXOOWNICQ-UHFFFAOYSA-N |
Canonical Smiles: | C1CN(CCN1C2CC3=CC=CC=C3C2)C4=C5C(=CC=C4)OCCO5 |
Isomeric Smiles: | C1CN(CCN1C2CC3=CC=CC=C3C2)C4=C5C(=CC=C4)OCCO5 |
Molecular Weight: | 336.4 |
Molecular Formula: | C21H24N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
S15535
Molecular Weight: | 336.4 |
Molecular Formula: | C21H24N2O2 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 25 |
Complexity: | 437 |
Synonyms
S15535
| S15535 | S15535 |
|---|---|
S15535 |
146998-34-7 |
S-15535 |
4-(Benzodioxan-5-yl)-1-(indan-2-yl)piperazine |
S 15535 |
1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-4-(2,3-dihydro-1h-inden-2-yl)-piperazine |
1-(2,3-dihydro-1,4-benzodioxin-8-yl)-4-(2,3-dihydro-1H-inden-2-yl)piperazine |
1-(2,3-dihydro-1H-inden-2-yl)-4-(2,3-dihydrobenzob1,4dioxin-5-yl)piperazine |
PDSP1_000559 |
ACMC-20ehn1 |
3HS-15535 |
GTPL26 |
GTPL32 |
CHEMBL49247 |
SCHEMBL1650175 |
BDBM82564 |
ZINC16050 |
DTXSID90163557 |
HMS3262P09 |
Tox21_500874 |
PDSP2_000557 |
AKOS025294533 |
CAS_132787 |
CCG-222178 |
LP00874 |
NSC_132787 |
SDCCGSBI-0633766.P001 |
1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-(2,3-dihydro-1H-inden-2-yl)piperazine |
Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-(2,3-dihydro-1H-inden-2-yl)- |
Piperazine,1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-(2,3-dihydro-1H-inden-2-yl)- |
NCGC00094198-01 |
NCGC00094198-02 |
NCGC00094198-03 |
NCGC00094198-04 |
NCGC00094198-05 |
NCGC00261559-01 |
AS-77738 |
S15535, >=98% (HPLC), solid |
D93384 |
4-(benzodioxan-5-yl)-1-(indan-2-yl)-piperazine |
L001121 |
Q286975 |
J-008300 |
Experimental Data
S15535
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -4.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
S15535
Statistics Data
S15535
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -4.000000000000000 | 1 | 1 |
Statistics Data Visualization
S15535
